Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Boill Healthcare Holdings Limited ( (HK:1246) ) has shared an update.
Boill Healthcare Holdings Limited has overhauled its corporate governance structure, announcing multiple changes to its board of directors, company secretary, authorised representatives and Hong Kong principal place of business. With effect from 30 December 2024, the company appointed Mr. He as an executive director, Dr. Tang as a non-executive director, and three new independent non-executive directors, Ms. Mak, Mr. Chan and Mr. Liang, each also taking up key roles on the audit, nomination and remuneration committees. Several former directors, including Mr. Qiu, Mr. Chui and Mr. Yi, resigned from the board and its committees, while Ms. Tang stepped down as an independent non-executive director in July 2024. Mr. Yu has been named executive director and chairman of the board effective 10 March 2025, and two directors, Mr. Wang and Mr. Zhang, were removed by board resolution on 19 February 2025, with Mr. Wang also leaving all board committees. The company replaced its company secretary, appointing Mr. Hui to the role from 30 December 2024, and designated Mr. He and Mr. Hui as authorised representatives in place of the outgoing officeholders. Concurrently, Boill Healthcare relocated its principal place of business in Hong Kong to new premises in Wan Chai, a move and management reshuffle that come in the context of resumption guidance previously issued by the Stock Exchange, underlining the company’s efforts to strengthen governance and move toward the resumption of trading in its shares.
More about Boill Healthcare Holdings Limited
Boill Healthcare Holdings Limited is a Hong Kong-listed company incorporated in the Cayman Islands, with its principal place of business in Hong Kong. The company operates within the healthcare-related sector, although this announcement focuses primarily on its corporate governance structure and regulatory compliance rather than specific products, services or market segments.
Technical Sentiment Signal: Sell
Current Market Cap: HK$28.52M
See more data about 1246 stock on TipRanks’ Stock Analysis page.